Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Torres

Showing results (411-420 of 523) with videos related to

Pageof 53
Sort By:
Stroke|August 10, 2021
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled TrialJose Jimenez-Torres, Juan F Alcalá-Diaz, Jose D Torres-Peña, et al.
The Journal of Clinical Endocrinology and Metabolism|October 29, 2024
Decreased Neutrophils Are Associated With Reduced Risk of Type 2 Diabetes Incidence: Results From the CORDIOPREV StudyHatim Boughanem, Antonio Pablo Arenas de Larriva, Antonio Camargo, et al.
Nutrition & Diabetes|May 16, 2024
Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trialAlicia Podadera-Herreros, Antonio P Arenas-de Larriva, Francisco M Gutierrez-Mariscal, et al.
European Journal of Nutrition|March 4, 2023
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV studyFrancisco M Gutierrez-Mariscal, Juan F Alcalá-Diaz, Gracia M Quintana-Navarro, et al.
Antioxidants (Basel, Switzerland)|January 26, 2024
Telomere Maintenance Is Associated with Type 2 Diabetes Remission in Response to a Long-Term Dietary Intervention without Non-Weight Loss in Patients with Coronary Heart Disease: From the CORDIOPREV Randomized Controlled TrialAna Ojeda-Rodriguez, Juan F Alcala-Diaz, Oriol Alberto Rangel-Zuñiga, et al.
Free Radical Biology & Medicine|November 30, 2023
Dietary antioxidant intake reduces carotid intima-media thickness in coronary heart disease patients: From the CORDIOPREV studyLorenzo Rivas-Garcia, Gracia M Quintana-Navarro, Jose D Torres-Peña, et al.
The American Journal of Clinical Nutrition|November 27, 2018
Long-term consumption of a Mediterranean diet improves postprandial lipemia in patients with type 2 diabetes: the Cordioprev randomized trialBeatriz Gomez-Marin, Francisco Gomez-Delgado, Javier Lopez-Moreno, et al.
Diabetologia|September 29, 2023
Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trialMerel M Ruissen, José D Torres-Peña, Bas S Uitbeijerse, et al.
Atherosclerosis|August 7, 2023
Association between telomere length and intima-media thickness of both common carotid arteries in patients with coronary heart disease: From the CORDIOPREV randomized controlled trialAna Ojeda-Rodriguez, Juan F Alcala-Diaz, Oriol Alberto Rangel-Zuñiga, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study)A Albasanz-Puig, C Gudiol, P Puerta-Alcalde, et al.
Pageof 53

Showing results (411-420 of 523) with videos related to

Sort By:
Pageof 53
Stroke|August 10, 2021
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled TrialJose Jimenez-Torres, Juan F Alcalá-Diaz, Jose D Torres-Peña, et al.
The Journal of Clinical Endocrinology and Metabolism|October 29, 2024
Decreased Neutrophils Are Associated With Reduced Risk of Type 2 Diabetes Incidence: Results From the CORDIOPREV StudyHatim Boughanem, Antonio Pablo Arenas de Larriva, Antonio Camargo, et al.
Nutrition & Diabetes|May 16, 2024
Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trialAlicia Podadera-Herreros, Antonio P Arenas-de Larriva, Francisco M Gutierrez-Mariscal, et al.
European Journal of Nutrition|March 4, 2023
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV studyFrancisco M Gutierrez-Mariscal, Juan F Alcalá-Diaz, Gracia M Quintana-Navarro, et al.
Antioxidants (Basel, Switzerland)|January 26, 2024
Telomere Maintenance Is Associated with Type 2 Diabetes Remission in Response to a Long-Term Dietary Intervention without Non-Weight Loss in Patients with Coronary Heart Disease: From the CORDIOPREV Randomized Controlled TrialAna Ojeda-Rodriguez, Juan F Alcala-Diaz, Oriol Alberto Rangel-Zuñiga, et al.
Free Radical Biology & Medicine|November 30, 2023
Dietary antioxidant intake reduces carotid intima-media thickness in coronary heart disease patients: From the CORDIOPREV studyLorenzo Rivas-Garcia, Gracia M Quintana-Navarro, Jose D Torres-Peña, et al.
The American Journal of Clinical Nutrition|November 27, 2018
Long-term consumption of a Mediterranean diet improves postprandial lipemia in patients with type 2 diabetes: the Cordioprev randomized trialBeatriz Gomez-Marin, Francisco Gomez-Delgado, Javier Lopez-Moreno, et al.
Diabetologia|September 29, 2023
Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trialMerel M Ruissen, José D Torres-Peña, Bas S Uitbeijerse, et al.
Atherosclerosis|August 7, 2023
Association between telomere length and intima-media thickness of both common carotid arteries in patients with coronary heart disease: From the CORDIOPREV randomized controlled trialAna Ojeda-Rodriguez, Juan F Alcala-Diaz, Oriol Alberto Rangel-Zuñiga, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study)A Albasanz-Puig, C Gudiol, P Puerta-Alcalde, et al.
Pageof 53